|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.26 USD | -1.65% |
|
-2.09% | +23.18% |
Investment objective
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 47.62EUR | +0.67% | +28.69% | 4.51% | |
| 5,555.00JPY | +1.37% | +14.89% | 4.37% | |
| 672.15USD | -0.67% | -12.92% | 4.33% | |
| 59.49USD | -3.77% | +101.73% | 4.29% | |
| 124.40USD | -2.43% | +18.18% | 4.25% | |
| 1,876.75GBX | -0.28% | +2.63% | 4.1% | |
| 1,828.50DKK | -1.00% | -9.77% | 4.05% | |
| 180.39USD | -3.10% | +126.48% | 4.03% | |
| 480.50USD | -1.06% | +5.99% | 4.01% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$32.26 | -1.65% | 34,248 |
| 26-07-17 | US$32.80 | +0.46% | 63,790 |
| 26-07-16 | US$32.65 | -1.42% | 20,097 |
| 26-07-15 | US$33.12 | +0.91% | 28,950 |
| 26-07-14 | US$32.82 | -0.39% | 28,606 |
Other stock markets
Delayed Quote NYSE
Last update July 20, 2026 at 04:00 pm
ETF Ratings
 |
Description
| US46435U1925 | |
|---|---|
| Total Expense Ratio | 0.47% |
| Asset Class | Stocks |
| Currency | |
| Provider | |
| Underlying | NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Fund Structure | |
| Date of creation |
2019-06-10
|
| Geographical Focus |
AuM evolution - 2026-02-26
| AuM (USD) | 159M |
|---|---|
| AuM 1M | 143M |
| AuM 3 months | 136M |
| AuM 6 months | 113M |
| AuM 12 months | 139M |
- Stock Market
- ETF
- IDNA ETF
Select your edition
All financial news and data tailored to specific country editions
